USANA Health Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Operating Leases (Tables)

Operating Leases (Tables)

12 Months Ended

Dec. 28, 2019

Operating Leases [Abstract]

Summary Of Lease Assets And Lease Liabilities In The Balance Sheet



				As of
Leases		Classification		December 28, ‎2019
Assets
ROU operating lease assets, net		Other assets		$	31,263
Total ROU assets				$	31,263

Liabilities
Current:
Operating lease liabilities		Other current liabilities		$	8,323
Non-current:
Operating lease liabilities		Other long-term liabilities			17,274
Total lease liabilities				$	25,597

Supplemental Lease Information



		Year Ended

		2019
Lease cost
Operating lease cost		$	8,988
Total lease cost		$	8,988



		Year Ended

		2019
Other information
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases		$	8,656
ROU assets obtained in exchange for new operating lease liabilities		$	13,575
Weighted-average remaining lease term—operating leases			3.85 yrs.
Weighted-average discount rate—operating leases			3.75%

Maturity Analysis For Operating Lease Liabilities



Year ending
2020				$	9,047
2021					7,013
2022					3,973
2023					3,371
2024					2,667
Thereafter					1,486
					27,557
Less: imputed interest					(1,960)
Present value				$	25,597

Schedule Of Future Commitments Under Operating Leases



Year ending
2019	$	9,155
2020		6,146
2021		3,825
2022		1,962
2023		1,464
Thereafter		2,514
	$	25,066